Uncovering the origins of malignant rhabdoid tumors
Researchers discover how malignant rhabdoid tumors begin, and identify potential treatments
Cancer Research
Cancer and clinical trials in the spotlight
March is still the month where we put extra attention on cancer, but the landscape is different in a pandemic
Focus Feature on Cancer
We explore advances in women’s cancers in addition to other recent oncology news
FDA approves Pepaxto
Oncopeptides’ Pepaxto has been approved for patients with triple-class refractory multiple myeloma
GENUINE progress
TG Therapeutics' GENUINE trial shows that ublituximab plus ibrutinib improves survival in patients with chronic lymphocytic leukemia
An alliance for drug development
UCLA researchers to select candidates for development with Xencor’s modular XmAb platforms
Bringing down the cost of cancer?
NuView’s theranostics approach could make cancer diagnosis and treatment more affordable
A different kind of TROLL
APIS and Moffitt pair up to assess TROLL lncRNAs as predictive biomarkers in cancer
In pursuit of pancreatic cancer
Study finds combination therapy with NAMPT inhibitors and STING agonists can suppress pancreatic tumor growth in mice
aTyr begins new tRNA programs
aTyr Pharma initiates two new tRNA synthetase discovery programs
